×

Pharmaceutical

Data
  • To date, 148 domestic enterprises produce more than 2000 kinds of medicines, which is more than 55% of the market share, which belong to 35 pharmacotherapeutic groups and are used in 28 areas of medicine;
  • 6,300 out of 8,500 drugs are imported;
  • 71 out of 350 medicinal plants, used in international medical practice, are cultivated in industrial plantations in the republic;
  • Uzbekistan as the only plant in Central Asia that specializes in manufacturing insulin drug used to treat diabetes;
  • 35.7% of the capital of pharmaceutical enterprises is the share of foreign partners, 64.3% of local participants.
Reasons to invest
  • Uzbekistan is located in the heart of Central Asia, since ancient times, trade routes connecting West and East passed here. Silk Road Restoration Project – One Belt One Road allows this historical advantage to be used today. In addition, the republic is part of the CIS, which provides many tax and customs benefits for export to the member countries. Uzbekistan exports 231 kinds of medicines and medical devices to 23 countries;
  • With a population of over 32 million, Uzbekistan is the most densely populated country in Central Asia; there is an extensive domestic market;
  • Uzbekistan is known for the abundance of herbs growing in mountainous areas, which is the reason for rich traditions of manufacturing medicines among the population. Over the past 20 years, about 30 original medicines have been developed on the basis of domestic plants and their production has been established;
  • In Uzbekistan there is a developed base for clinical research. There are 8 scientific research institutes and centers that conduct research on creation of new drugs and active substances. Pharmaceuticals are turning into a developed industry that can produce medicines and medical devices, in addition to everything, provides medicines for the domestic market by 49.8%;
  • Pricing in the Republic of Uzbekistan is significantly lower than in the USA and Europe, which allows it to be competitive in the international market.
Growth factors
  • The decree of the President provides for development of a target program for the creation of industrial plantations and a list of specific types of medicinal plants recommended for cultivation, with organization of deep processing and production of medicines and dietary supplements;
  • In recent years, the volume of products increased by 3.1 times;
  • More than $300 million investments were attracted to the pharmaceutical sector, including $120 million from foreign direct investment.
Priorities

According to the data of certifying authorities, in 2017 the following pharmacological groups of drugs were the most demanded:

  • Anti-rheumatic, anti-arthritic, analgesic and antipyretic drugs;

  • Antibiotics;

  • Means for correction of metabolic processes;

  • Antiseptic and disinfectants;

  • Plasma substitutes and salt solutions, solvents;

  • Drugs for treatment of respiratory diseases;

  • Antibacterial and synthetic agents;

  • Antiparasitic and antiprotozoal agents;

  • Agents for treating the pathology of the gastrointestinal tract;

  • Cardiovascular agents;

  • Agents for anaesthesiology and resuscitation;

  • Agents affecting the function of the nervous system.

State support
  • For the development of pharmaceutical industry in six regions of Uzbekistan, seven specialized free economic zones have been created. Taking into account the climatic conditions of the FEZ, it was decided to open in Karakalpakstan – Nukus-pharm, Jizzakh region – Zomin-pharm, Namangan – Kosonsoy-pharm, Syrdarya – Sirdaryo-pharm, Surkhandarya – Boysun-pharm and Tashkent region – Bustonlik-pharm and Parkent-pharm companies;
  • The terms of functioning of the created FEZs is 30 years, with the possibility of extension;
  • Special tax, customs and foreign exchange regimes will apply on the territory of these zones;
  • The state provides agricultural land and production areas on preferential terms
Realized projects

Название региона

Кол-во проектов

Сумма иностранных инвестиционных вложений

Собственные средства

Кредиты банков

ввод в эксп.

 (тыс. долл США)

(млн.   сум)

%

(млн. сум)

%

(млн. сум)

%

2018

2019

1

Республика Каракалпакстан

12

3 404

27 232 000

99,64

34 650

0,13

62 720

0,23

11

1

2

Андижанская область

15

800

6 400 000

96,61

80 927

1,22

143 470

2,17

11

4

3

Навоийская область

1

 

 

0,00

200

57,14

150

42,86

1

0

4

Наманганская область

14

1 500

12 000 000

97,96

249 700

2,01

200 380

1,61

7

7

5

Самаркандская область

13

5 525

44 200 000

98,94

133 633

0,30

339 016

0,76

8

5

6

Ташкентская область

18

8 441

67 528 000

99,34

139 393

0,21

311 998

0,46

11

7

7

Ферганская область

8

9 180

73 440 000

99,88

53 866

0,07

34 670

0,05

2

6

8

Ташкент

12

1000

8 000 000

97,56

108 731

1,33

91 340

1,11

12

0

9

Жиззакская область

8

91 000

728 000 000

99,96

173 242

0,02

82 917

0,01

3

5

10

Бухарская область

1

1 800

14 400 000

99,86

3000

0,02

17 400

0,12

1

0

11

Кашкадарьинская область

2

 

0

0,00

20 090

36,47

35 000

63,53

1

1

12

Сурхандарьинская область

7

 

0

0,00

20 354

55,91

16 049

44,09

4

3

13

Хорезмская область

9

 

0

0,00

29 175

34,87

54 487

65,13

8

1

14

Сырдарьинская область

16

4 500

36 000 000

96,17

669 790

1,79

765 538

2,04

9

7

         Общее

136

127 150

 

 

1 724 751

 

2 171 136

 

89

47

Representative offices, companies with foreign shares

Abbott Laboratories SA (Германия)

СП ООО Barakat Pharma

Arterium (Украина)

СП ООО Bagil Medical-New Technology

Bayer Pharma AG (Германия)

ИП ООО Codepharm

Bayer Pharma AG (Германия)

CП ООО Gufik-Avicenna

Berlin-Chemie AG (Германия)

СП ООО «Guliston Med Texnika»

Борщаговский химико-фармацевтический завод ПАО НПЦ (Украина)

CП ООО Jurabek Laboratories

ИП ООО KHIVA

Gedeon Richter (Венгрия)

СП ООО Le Uat De Buxara

GSK (GlaxoSmithKline Export Ltd.) (Англия)

СП ООО Merrimed Farm

F.Hoffman La Roche Ltd. (Швейцария)

ИП ООО Neogalenpharm

Laboratoire Innotech International (Франция)

ИП ООО Nobel-Pharmsanoat  

Нижфарм (Россия)

ДХО Nikapharm

Polpharma S.A. (Польша)

CП ООО Novopharma plus

Sandoz Pharmaceuticals (Швейцария)

CП ООО Samarkand-England_eco-Medical

Sanofi-Aventis Groupe (Франция)

CП ООО Remedy

Takeda Osteurope Holding GmbH (Австрия)

CП ООО Reka-Med Farm

Unipharm Inc (США)

CП ООО Samsun-Tashkent Farm

Frankopharm Group (Латвия)

СП ООО Ultra Health Care

СП OOO ACL Meditek

CП ООО UzGerMed Pharm

СП ООО Asia Trade

СП ООО UzKorea Medical

СП OOO Asklepiy-Svift

ИП ООО Well med Farm

ИП ООО ATM Sanita Pharma

 

Ministries and agencies of Uzbekistan that assist in the sphere of pharmaceutics

Ministry of Investments and Foreign Trade of the Republic of Uzbekistan

Agency for development of the pharmaceutical industry under the Ministry of Health of the Republic of Uzbekistan

Ministry of Health of the Republic of Uzbekistan

Ministry of Economy and industry of the Republic of Uzbekistan

Ministry of Finance of the Republic of Uzbekistan

Tashkent city khokimiyat and regional khokimiyats